Ocugen

Ocugen Secures EMA Orphan Designation for OCU410ST, Advancing Stargardt Disease Treatment

MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) has received orphan medicinal product designation from the European Medicines Agency (EMA) for OCU410ST, a promising treatment for ABCA4-associated retinopathies including Stargardt disease, …

Ocugen Secures EMA Orphan Designation for OCU410ST, Advancing Stargardt Disease Treatment Read More


Trinseo

Trinseo Enters Strategic Agreement with Deepak Nitrite Limited for Polycarbonate Technology Transfer

WAYNE, PA — Trinseo (NYSE: TSE) has announced a significant agreement to supply its polycarbonate technology license and production equipment from Stade, Germany, to Deepak Nitrite Limited’s subsidiary in India. …

Trinseo Enters Strategic Agreement with Deepak Nitrite Limited for Polycarbonate Technology Transfer Read More